Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1992 | 09-1992 | |
| Sales | 1,953 | 3,757 |
| Gross Profit | 1,953 | 3,757 |
| Operating Income | 1,953 | 3,757 |
| Pre-tax Income | 1,953 | 3,757 |
| Net Income Continuous | -8,152 | -3,525 |
| Net Income Discontinuous | -1,408 | 0 |
| Net Income | $-9,560 | $-3,525 |
| EPS Basic Total Ops | -18.71 | -6.84 |
| EPS Basic Continuous Ops | -16.13 | -6.91 |
| EPS Basic Discontinuous Ops | -2.79 | N/A |
| EPS Diluted Total Ops | -19.07 | -6.84 |
| EPS Diluted Continuous Ops | -16.13 | -6.91 |
| EPS Diluted Discontinuous Ops | -2.79 | N/A |
| EBITDA(a) | $1,953 | $3,757 |